| Open Document File Size: 153,88 KBShare Result on Facebook
City Ridgefield / / Company Boehringer Ingelheim Pharmaceuticals Inc. / / Event FDA Phase / / / IndustryTerm treatment of HIV / / MedicalCondition hypertension / Nervous System Disorders / disease / headache / both fatal and non-fatal intracranial hemorrhage / Intracranial Hemorrhage / hyperglycemia / alcohol abuse / intracranial hemorrhage events / nausea / hepatitis C / hepatitis B / vomiting / maculopapular rash / fatigue / diabetes mellitus / clinical hepatitis / RITONAVIR HAS BEEN ASSOCIATED WITH REPORTS OF BOTH FATAL AND NON-FATAL INTRACRANIAL HEMORRHAGE / AIDS / head trauma / hypersensitivity / diarrhea / urticarial rash / WARNINGS Intracranial Hemorrhage APTIVUS / rash / hepatic decompensation / chronic hepatitis B / hemophilia / syndrome / hepatic insufficiency / Immune reconstitution syndrome / sulfonamide allergy / / MedicalTreatment antiretroviral treatment / antiretroviral therapy / neurosurgery / surgery / / Organization FDA / Boehringer Ingelheim Pharmaceuticals Drug Information Unit / Drug Information Unit / / / Position physician / / Product fluticasone propionate / Aptivus / estradiol / simvastatin / triazolam / rifampin / lovastatin / / ProvinceOrState Connecticut / / PublishedMedium Microbiology / / Technology neurosurgery / / URL www.APTIVUS.com / www.FDA.gov/medwatch / /
SocialTag |
ABCD Subject: Important Safety Information: Intracranial Hemorrhage in Patients Receiving Aptivus® (tipranavir) capsules Boehringer Ingelheim Pharmaceuticals, Inc.